TCL Archive Educational Strategies On Mammography, Not Guidelines, To Come From NCAB February 28, 1997
TCL Archive Genentech Move Nixes Hospital Discounts: Avastin, Herceptin, Rituxan Now Sold Under Tighter Control by Drug Maker October 3, 2014
TCL Archive Chemical Distribution To Grantees Delayed while HEW Considers Charging For It June 22, 1979
TCL Archive ODAC Nixes Abraxane for Adjuvant Breast Cancer, While Genasense Falls Victim to Its Randomized Trial. September 8, 2006
